Here's how you can reach us...
  • Tel:
  • Email:

Cell-Free Expression Technology

Inquiry

Cell-free expression systems have become a mature technology for synthesizing proteins in cell lysates. CD Formulation integrates cell-free expression technology into our internal protein production platform, offering the ultimate solution for your protein production. Our services can be tailored to your specific requirements (e.g., tag selection, purity).

What is The Cell-Free Expression Technology?

Cell-free protein expression, also known as in vitro translation, cell-free translation, and cell-free protein synthesis, is a method of synthesizing proteins in vitro that can produce target proteins without the use of living cells. Because this protein synthesis occurs in cell lysates rather than in cultured cells, this method is called cell-free. This technology enables researchers to quickly express and manufacture small amounts of functional proteins. Compared to in vivo techniques in bacteria or tissue culture cells, cell-free protein expression is fast because no gene transfection, cell culture, or extensive protein purification is required.

Fig. 1 Cell-free protein synthesis.Fig. 1 The components of a cell-free protein synthesis reaction. (Brookwell A, et al., 2021)

Our Services Related to Cell-Free Expression Technology

CD Formulation is one of the world leaders in the production of therapeutic proteins using advanced cell-free protein synthesis technology. Thanks to the innovative cell-free protein synthesis system (CFPS), we can handle difficult proteins that show no/low expression, aggregation, etc. in other systems. The expression process that originally took several days has been optimized and shortened to a few hours.

Our personalized cell-free protein synthesis service can flexibly express proteins according to the specific needs of our customers. By introducing the desired nucleotide modifications in the transcribed tRNA, we can help increase the freedom of regulation of the translation process.

Our services include but are not limited to:

Gene Synthesis and Codon Optimization (Optional)

  • Start with the antibody sequence

Vector Construction (Optional)

  • Cloning into an expression vector
  • Plasmid sequencing
  • Plasmid generation
  • Cell-free expression and purification

Quality Control (QC)

  • SDS-PAGE
  • UV
  • SEC-HPLC

Deliverables

  • Purified protein

Key Components and Processes of Cell-Free Expression Technology

Two basic components of cell-free protein expression are a genetic template (plasmid DNA, linear DNA, or mRNA) encoding the protein of interest and a reaction solution containing the necessary molecular machinery for transcription and translation.

In CFPS, our scientists use a solution containing all the cellular machinery required to direct protein synthesis to transcribe and translate the provided nucleic acid template.

Common cell extracts contain most or all of the molecules in the reaction solution, including:

  • RNA polymerase for mRNA transcription.
  • Ribosomes for polypeptide translation.
  • tRNA and amino acids.
  • Enzyme cofactors and energy sources.
  • Necessary cellular components for correct protein folding.

Different Cell-Free Expression Systems

Extracts from cell-free expression are made using different systems to support high levels of protein synthesis. The following table lists the common cell-free expression systems.

E. coli Wheat Germ Insects Mammals Humans
Yield High Medium Medium-Low High Low
Phosphorylation No Yes Yes Yes Yes
Glycosylation No No Yes Yes Yes
Advantages
  • Very high protein yield.
  • High tolerance to additives.
  • Large proteins can be translated with high protein yields.
  • No off-target endogenous mammalian proteins.
  • No endogenous mammalian proteins.
  • Possibility of some forms of protein glycosylation.
  • Mammalian systems.
  • Cap independent translation.
  • Possibility of co-PTM and post-PTM.
  • Functional protein synthesis.
Disadvantages
  • Impossibility in eukaryotic co-PTMs and post-PTMs.
  • Eukaryotic protein insoluble in expression.
  • Impossibility in mammalian co-PTMs and post-PTMs.
  • Premature termination of products.
  • Non-mammalian.
  • Sensitive to additivesImpossible of protein glycosylation.
  • Co-expression of off-target proteins.
  • New system sensitive to additives
  • Lower yield than E.coli.

Custom Cell-Free Expression Services

Therapeutic Protein Production

The cell-free expression system is an efficient protein expression technology that can quickly synthesize the target protein. Our innovative cell-free protein expression platform can produce protein drugs efficiently and safely to support your research.

Features of Cell-Free Expression Technology

  • Cell-free reactions are easy to set up and require only a few hours to express proteins.
  • Using small-scale reactions (50-100uL), reaction conditions can be optimized quickly and in parallel.
  • Milligram quantities of soluble protein can be obtained from a few milliliters of reaction volume.
  • Eukaryotic cell-free lysates provide post-translational modifications such as core glycosylation or phosphorylation and native membrane components for membrane protein insertion.
  • Proteins and complexes with multimeric conformations can be expressed.
  • The open system allows the addition of many components to the reaction, such as molecular chaperones, labeled xenyl acids, or detergents, allowing for direct manipulation of the chemical environment.

Publication

Published Data

Technology: Cell-Free Expression Technology

Journal: Cell Chem Biol.

IF: 6.68

Published: 2019

Results:

The authors developed a high-yield, one-pot cell-free platform for the synthesis of ncAA-bearing proteins. The platform did not require the addition of purified T7 DNA-directed RNA polymerase (T7RNAP) to catalyze transcription. The ability of extracts from the resulting transformants to catalyze CFPS in the absence of exogenous polymerase supplementation was evaluated. Finally, using the optimized one-pot platform, multisite incorporation of the ncAA acetyl-L-phenylalanine into elastin-like polypeptides was demonstrated with high accuracy and high yield.

Fig. 2 The production from E. coli cells to catalyze cell-free protein synthesis.Fig. 2 Simplified schematic of the production and utilization of crude lysates from E. coli cells to catalyze cell-free protein synthesis. (Des Soye, et al., 2019)

Thanks to our in-house advanced cell-free expression platform, CD Formulation is committed to providing efficient and economical production of therapeutic proteins. Please feel free to contact us if you are interested in our services. Learn how our cell-free expression technology can support your recombinant protein synthesis projects.  

References

  1. Brookwell A, Oza JP, Caschera F. Biotechnology Applications of Cell-Free Expression Systems. Life (Basel). 2021 Dec 8;11(12):1367.
  2. Des Soye BJ, Gerbasi VR, Thomas PM, et al. A Highly Productive, One-Pot Cell-Free Protein Synthesis Platform Based on Genomically Recoded Escherichia coli. Cell Chem Biol. 2019;26(12):1743-1754.e9.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services

CD Formulation is an expert in formulation science and pharmaceutical process development in therapeutic proteins & peptides, dedicated to supporting biotherapeutics development and production...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.